COMMUNIQUÉS West-GlobeNewswire

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
27/04/2026
WARREN, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced continued progress within its artificial intelligence initiative, Tevogen.AI, including [...]
AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors
27/04/2026
PRESS RELEASE AB SCIENCE announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors AB Science has reached a final agreement with its financial creditors [...]
Virbac : Communiqué de mise à disposition du Rapport Annuel de Virbac au 31 décembre 2025
27/04/2026
Communiqué de mise à disposition du Rapport Annuel de Virbac au 31 décembre 2025. Le Groupe annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers son Rapport Annuel au format [...]
Virbac : Rapport Annuel Virbac au 31 décembre 2025 (ESEF)
27/04/2026
Veuillez trouver le Rapport Annuel du Groupe au format ESEF au 31 décembre 2025 Pièce jointe Rapport_Annuel_Virbac_2025_XBRL
EssilorLuxottica: Disclosure of transactions in own shares
27/04/2026
Disclosure of transactions in own shares Paris, France (April 27, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that on [...]
KFSH Joins Milken Institute Global Conference 2026 in Beverly Hills, California, as a Silver Sponsor
27/04/2026
BEVERLY HILLS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will participate as a Silver Sponsor at the Milken Institute Global Conference 2026, taking place in [...]
Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026
27/04/2026
Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data at ASGCT Additional Presentations at ASGCT Showcase Tenaya’s Work with Patients to Advance [...]
Hyperion DeFi Announces Participation in Upcoming Investor and Industry Conferences
27/04/2026
LAGUNA HILLS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that [...]
Addgene Reinforces Its Expanding Role in Research with New Brand
27/04/2026
Marked by decades of scientific partnership, Addgene’s evolution from a pioneering plasmid repository to a trusted resource spanning all stages of research drives refreshed brand WATERTOWN, Mass., April 27, 2026 (GLOBE [...]
TOMI Environmental Solutions, Inc. Sees Strong Interest In Its Solutions at INTERPHEX 2026
27/04/2026
Company Showcases SteraMist iHP Automation to Industry Giants Including Amgen, Merck, and Moderna; Finalizes Custom Engineering Contract for Proprietary Healthcare System FREDERICK, Md., April 27, 2026 (GLOBE NEWSWIRE [...]
NEXGEL Appoints Ian Blackman as Chief Financial Officer
27/04/2026
Veteran Financial and M&A Leader Appointed to Integrate Acquisition of Celularity, Scale the Business and Accelerate Growth LANGHORNE, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company [...]
Siren Biotechnology Publishes Foundational AAV Immuno-Gene Therapy Data and Announces Presentations at ASGCT 2026
27/04/2026
SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology today announced the publication of its first peer-reviewed manuscript in Molecular Therapy Oncology , alongside upcoming presentations at the [...]
Polyrizon Announces Filing of European Patent Application for Its Breakthrough Drug Delivery Platform
27/04/2026
Raanana, Israel, April 27, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
Solana Company (NASDAQ: HSDT) Announces Registered Direct Offering of Common Stock to Global Institutional Investor
27/04/2026
NEWTOWN, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (“HSDT” or the “Company”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to [...]
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
27/04/2026
On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration’s final order rescheduling FDA-approved cannabis drug products and state-licensed medical cannabis from Schedule I to Schedule III of [...]
TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call
27/04/2026
First Quarter 2026 Net Revenue Totaled $65.5 million with Gross Profit Margin of 52.8% TORONTO, April 27, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading [...]
Backed by Goldman Sachs, Urgent Care Provider Xpress Wellness Appoints New Chief Operating Officer to Support Continued Growth
27/04/2026
New COO Joe Willey brings experience leading large-scale, people-first organizations to support expanding access to care across rural and suburban communities OKLAHOMA CITY, April 27, 2026 (GLOBE NEWSWIRE) -- Xpress [...]
Sharecare surpasses 1 million hours of home care delivered to Veterans through U.S. Department of Veterans Affairs Community Care Network
27/04/2026
Collaboration between Sharecare and Red Duke Strategies enables Veterans’ friends or family members to become certified professional caregivers, significantly improving both quality of and access to care through VA- [...]
Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload
27/04/2026
Patent covers proprietary 2nd generation Thailanstatin analog payload designed for use in ADCs (antibody-drug conjugates) targeting cancer Approval strengthens Akari’s global intellectual property across all major [...]

Pages